North Korea’s Pugang Pharmaceutical has recently entered the Russian market with a range of its products, despite ongoing international sanctions. The company, which has been under UN, US, and EU restrictions due to its alleged ties to military entities and involvement in the sale of questionable medical products, has registered a new brand in Russia.
The company is known for marketing what it describes as “miracle” medicines, though these products have faced criticism regarding their efficacy and safety. Reports indicate that Pugang Pharmaceutical has a history of selling pseudo-medicines at inflated prices, targeting markets with limited regulatory oversight.
The recent registration in Russia has raised concerns among health and regulatory authorities, who note that the company’s products may pose health risks to consumers. International observers continue to monitor Pugang Pharmaceutical’s activities closely, given its background and the potential for the sale of non-evidence-based treatments.
As of now, Russian authorities have yet to issue specific statements regarding the new registration, but experts emphasize the importance of rigorous evaluation and oversight to protect consumers from potentially harmful products associated with companies under sanctions.